Figure S1    TAC IVS, mm 0 0.6 1.2 0.3 0.9 TAC LVPW, mm 0 0.6 1.2 0.3 0.9 n.s. TAC LVDd, mm 0 2 4 6 TAC LVDs, mm 0 2 4 1 3 TAC LVFS, % 0 20 40.

Slides:



Advertisements
Similar presentations
 -SMA α- Tubulin CLIC4 AD-CLIC TGF-  Supplementary Figure 1 Supplementary Figure 1. Exogenous CLIC4 expression enhances α-SMA expression.
Advertisements

Supplemental Figure 1. Remicade treatment did not affect body weight and muscle weight in mdx mice. Mdx mice were treated with Remicade (10 mg/ml) starting.
Supplemental figure 1 (S1) Levels of circulating AngII. There is a significant higher amount of circulating AngII in both AngII (+) / OA- NO 2 (+) (n=9)
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: EUK-8, a Superoxide Dismutase and Catalase Mimetic,
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: 17-Beta-Estradiol increases cardiac remodeling and.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of ATP-Sensitive Potassium Channel Agonists.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduced Collagen Deposition in Infarcted Myocardium.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Load-Reducing Therapy Prevents Development of Arrhythmogenic.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Peroxisome Proliferator-Activated Receptor-γ.
Supplementary Figure S4
Parameter WT Rnd3+/- n 7 Body weight (g) 25.59± ±2.11
From: Baicalein Inhibits Amadori-Glycated Albumin-Induced MCP-1 Expression in Retinal Ganglion Cells via a MicroRNA-124–Dependent Mechanism Invest. Ophthalmol.
Journal of Molecular and Cellular Cardiology
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Imatinib Mesylate Attenuates Myocardial Remodeling Through Inhibition of Platelet-Derived Growth Factor and Transforming Growth Factor Activation in a.
MicroRNAs Involved in the Mitogen-Activated Protein Kinase Cascades Pathway During Glucose-Induced Cardiomyocyte Hypertrophy  E. Shen, Xuehong Diao, Xiaoxia.
Loss of Secreted Frizzled-Related Protein-1 Leads to Deterioration of Cardiac Function in Mice and Plays a Role in Human CardiomyopathyCLINICAL PERSPECTIVE.
Mitogen‐Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation–Induced Cardiac Hypertrophy by Mai Chen, Jiajia.
AMPK Dilates Resistance Arteries via Activation of SERCA and BKCa Channels in Smooth MuscleNovelty and Significance by Holger Schneider, Kai Michael Schubert,
Volume 41, Issue 4, Pages (October 2004)
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Bindiya Patel et al. BTS 2018;3:
Volume 136, Issue 4, Pages e3 (April 2009)
Topical Application of 17β-Estradiol Increases Extracellular Matrix Protein Synthesis by Stimulating TGF-β Signaling in Aged Human Skin In Vivo  Eui Dong.
Volume 125, Issue 6, Pages (December 2003)
Volume 124, Issue 5, Pages (May 2003)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 83, Issue 5, Pages (May 2013)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 62, Issue 4, Pages (October 2002)
Volume 44, Issue 3, Pages (November 2011)
Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C
Histamine Contributes to Tissue Remodeling via Periostin Expression
Marisol Quezada, Ph. D. , Jikui Wang, Ph. D. , Valerie Hoang, M. S
Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β  Y. Xiang, M.D., K. Masuko-Hongo,
Volume 11, Pages (January 2019)
Nikole J. Byrne et al. BTS 2017;j.jacbts
Volume 86, Issue 3, Pages (September 2014)
Volume 3, Issue 5, Pages (May 1999)
Volume 74, Issue 2, Pages (July 2008)
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Volume 12, Issue 4, Pages (October 2003)
Cardiac Fibrosis at 18 Weeks Post TAC (A) Representative images (original magnification ×20) of Picrosirius red-stained cardiac tissue sections from HF +
Volume 137, Issue 4, Pages (October 2009)
Hironori Hara et al. BTS 2018;3:
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Volume 62, Issue 1, Pages (July 2002)
Isabelle Plaisance et al. BTS 2016;j.jacbts
Volume 92, Issue 3, Pages (September 2017)
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Volume 124, Issue 7, Pages (June 2003)
Chi-Hyun Park, Youngji Moon, Chung Min Shin, Jin Ho Chung 
R. Parekh, M.K. Lorenzo, S.Y. Shin, A. Pozzi, A.L. Clark 
TNF-α Suppresses α-Smooth Muscle Actin Expression in Human Dermal Fibroblasts: An Implication for Abnormal Wound Healing  Mytien T. Goldberg, Yuan-Ping.
Involvement of αvβ5 Integrin in the Establishment of Autocrine TGF-β Signaling in Dermal Fibroblasts Derived from Localized Scleroderma  Yoshihide Asano,
Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: Potential role of histamine in airway remodeling  Steffen Kunzmann,
Volume 25, Issue 1, Pages (January 2017)
LV Structure, Function, and Circulating BNP Levels at 18 Weeks Post TAC (A) (B) LVEDD and LVESD (mm) throughout the experimental protocol. (C) Percent.
Smad3 and Extracellular Signal-Regulated Kinase 1/2 Coordinately Mediate Transforming Growth Factor-β-Induced Expression of Connective Tissue Growth Factor.
Volume 70, Issue 5, Pages (September 2006)
Supplementary Figure 5: Effect of S48168 on normalized organ and skeletal muscle weights after 12 weeks of treatment for all the experimental groups from.
Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse myocardium. Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse.
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
PTx pretreatment abrogates the glucagonostatic effect of high glucose concentrations. PTx pretreatment abrogates the glucagonostatic effect of high glucose.
(fold of TGF-β1 response)
Effects of Hepatocyte Growth Factor on the Expression of Type I Collagen and Matrix Metalloproteinase-1 in Normal and Scleroderma Dermal Fibroblasts 
Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression  Atsushi Otsuka, MD, PhD, Hiromi Doi, MS, Gyohei.
miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure
The Different Roles of miRNA-92a-2-5p and let-7b-5p in Mitochondrial Translation in db/db Mice  Huaping Li, Beibei Dai, Jiahui Fan, Chen Chen, Xiang Nie,
Presentation transcript:

Figure S1    TAC IVS, mm TAC LVPW, mm n.s. TAC LVDd, mm TAC LVDs, mm TAC LVFS, % * n.s. * * * * * Supplementary Figures Comparison of echocardiographic data after TAC among wild type, heterozygous knockout, and homozygous knockout mice. Echocardiography was performed after TAC operation in wild type (GCLM  ), heterozygous knockout (GCLM  ) and homozygous (GCLM  ) mice. n = 10 in each experiment. n.s. indicates not statistically significant. *P < 0.05.

t-Smad3 p-Smad3 A D p- / t-Smad   TGF  GSH-EE * *   * †† †† B TGF  GSH-EE   † † † † 7.5 † † C   CTGF mRNA expression Procollagen III mRNA expression Procollagen I mRNA expression   TGF  GSH-EE   TGF  GSH-EE     * †† †† † † * †† †† Smad3 phosphorylation and expression of CTGF and procollagen in cultured mouse cardiac fibroblasts The cultured cardiac fibroblasts were incubated with TGF-  1 (25 ng/mL) or vehicle in the presence or absence of GSH-EE (2 mmol/L). (A), Smad3 phosphorylation after the incubation for 24 hrs. Upper panel shows representative blotting. (B-D), mRNA expression of CTGF and procollagen I and III after the incubation for 24 hrs and 4 hrs, respectively. The mRNA levels were normalized to GAPDH mRNA expression. n = 10 in each experiment. +/+ denotes GCLM +/+ mice and  denotes GCLM  mice. *P < †P < The data were expressed relative to the GCLM +/+ fibroblasts treated with vehicle in the absence of GSH-EE (= 1). Figure S2

A TGF-  R2 mRNA expression Sham TAC +/+  * B Sham TAC +/+  TIMP-2 mRNA expression D F/F /+  Time (second) F * GSH / GSSG * * PBS GSH PBS GSH +/+  Figure S3 Myocardial expression of TGF-  R2 and TIMP-2 and microvessel density after TAC, transients of intracellular calcium concentration in cultured cardiomyocytes and effect of GSH-EE supplementation on myocardial microvessel density and GSH/GSSG ratio. (A, B), TGF-  R2 and TIMP-2 mRNA expression. The expression levels were normalized to GAPDH mRNA expression and are shown relative to the levels in sham-operated GCLM +/+ myocardium (= 1). (C), Microvessel number per mm 2 in myocardium after TAC. (D), Representative tracing of transients of intracellular calcium concentration in cultured cardiomyocytes in response to electrical stimulation. (E, F), Effects of GSH-EE supplementation during TAC on myocardial microvascular density and GSH/GSSG ratio.  /  denotes GCLM  /  mice, and +/+ denotes GCLM +/+ mice. n = 6 in each experiment. *P < * Sham TAC +/+  Vessels / mm 2 x 1000 C * * PBS GSH +/+  No Treat. Vessels / mm 2 x 1000 E

ABC Heart rate LVEDP TAC n.s. ** +/+ with no treatment  with PBS  with GSH-EE bpm mmHg * * EF Max dp/dtMin dp/dt TAC * * mmHg/sec D Tau TAC * * ms Systolic BP at aortic root n.s. Figure S4 Effects of GSH-EE supplementation on hemodynamic data 4 weeks after TAC operation in GCLM  mice. Hemodynamic study was performed in GCLM  mice after treatment with GSH-EE or PBS as a placebo and in GCLM +/+ mice with no treatment for 4 weeks after TAC operation. n = 6 in each experiment. n.s. indicates not statistically significant. *P < 0.05.